Professor Nathaniel Martin obtained his PhD degree from the University of Alberta in 2004 and subsequently performed postdoctoral studies at the University of California Berkeley. In 2007 Prof. Martin established his independent research group at Utrecht University (The Netherlands) and in 2018 moved to Leiden University where he is currently Chair of Biological Chemistry. The Martin research group works on developing molecular strategies to address antibiotic resistance (www.martinlab.nl). With a firm foundation in bioorganic and medicinal chemistry, the approaches used by the Martin lab include the design and (semi)synthesis of new antibiotics as well as developing small molecule inhibitors of different resistance mechanisms. To date, Prof. Martin has published >150 research papers and is named inventor on 13 patents. Prof. Martin is also co-founder of two Leiden University spinout companies with one focused on developing novel antibiotics to combat bacterial infections and the other aimed at developing innovative treatments for cardiometabolic disease. Prof. Martin is also an associate editor for the Journal of Medicinal Chemistry, where he oversees submissions on infectious disease.